Zeptosens AG and ViaLogy Corp. today announced the results from an extensive, blinded study using Zeptosens' planar waveguide (PWG) based microarray technology and Vialogy's Quantum Resonance ...

Microarrays have been described as a technology that will revolutionise medicine with the ultimate goal to develop effective treatments or cures for every human disease by 2050 (Ioannidis, 2005a). It ...

A substantial percentage of microarray-based studies in oncology contain critical flaws in analysis or in their conclusions, reports a study in the Jan. 17 issue of the Journal of the National Cancer ...

A study funded by the National Cancer Institute, part of the National Institutes of Health, shows for the first time that microarray data generated in different laboratories can produce highly ...

The collaborative Microarray Innovations in Leukemia (MILE) study program was designed to assess the clinical accuracy of gene expression profiles (compared with current routine diagnostic work-up) of ...

The ability to perform large-scale analysis of the genome at the level of gene sequence, gene copy number and messenger RNA transcript expression characterizes the post-genomic era. In the past decade ...

Yes, many are attracted to next-generation sequencing, but loyalty to chip-based phenotyping has its rewards, particularly in screens of large sample sets. The microarray, the legacy technology for ...

Thanks to new advances, breast cancer can be a beatable disease, but there is still a lot we do not know about breast cancer. New technology is helping doctors learn more. Researchers at UNC are using ...

SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) today announced that the United States-Latin American Cancer Research Network (US-LACRN) has selected Agilent Gene Expression ...

The Microarray Innovations in Leukemia study assessed the clinical utility of gene expression profiling as a single test to subtype leukemias into conventional categories of myeloid and lymphoid ...